Skip to content
The Good Wealth

Nippon India Pharma Fund - Direct Plan - Growth Option

Nippon India Mutual Fund · Sectoral Fund

NAV as of 9 Sept 2026

₹643.4016

1y return
+12.37%
absolute
3y return
+19.05%
CAGR
5y return
+13.83%
CAGR
NAV history
27 Jul 20219 Sept 2026

Low ₹274.9712High ₹653.6135

Scheme details

Fund house
Nippon India Mutual Fund
Category
Equity Schemes - Sectoral Fund
Plan
Direct Plan
Option
Growth Option
AMFI scheme code
118759
ISIN (growth / payout)
INF204K01I50
ISIN (reinvestment)
52-week high
₹653.6135
52-week low
₹539.2707

SIP projection

An illustration only. The rate below is an assumption, not a forecast, and actual returns will differ.

Amount invested
6,00,000
Projected value at 19.1% p.a.
18,03,845

Other variants of this fund

SchemeNAV1y
Nippon India Pharma FundDirect · Bonus Option₹643.4016+12.37%
Nippon India Pharma FundDirect · IDCW Option₹176.0854+4.15%
Nippon India Pharma FundRegular · Bonus Option₹571.8441+11.39%
Nippon India Pharma FundRegular · Growth Option₹571.8441+11.39%
Nippon India Pharma FundRegular · IDCW Option₹123.4863+3.20%

Sectoral Fund peers, sorted by 1-year return

Same plan and option, from other fund houses. Sorted by a fact, not a recommendation.

SchemeNAV1y
WhiteOak Capital Pharma and Healthcare FundDirect · Growth Option₹17.846+24.09%
Nippon India Power & Infra FundDirect · Growth Option₹416.2562+12.35%
WhiteOak Capital Banking & Financial Services FundDirect · Growth Option₹13.415+5.43%
Nippon India Banking & Financial Services FundDirect · Growth Option₹702.0045+5.30%
WhiteOak Capital Digital Bharat FundDirect · Growth Option₹10.441−1.35%

Thinking about this fund?

Talk to The Good Wealth about whether it fits your goals and how to invest.

Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance is not indicative of future returns. NAV data is sourced from AMFI and may be delayed. The Good Wealth is an AMFI-registered mutual fund distributor and does not provide investment advice.